53 Biggest Movers From Friday
Gainers
Blue Star Foods Corp. (NASDAQ: BSFC) shares climbed 100% to close at $3.80 on Friday after gaining around 9% on Thursday.
BofA Downgrades CureVac On Limited 2022 Prospects
There is limited upside from CureVac BV’s (NASDAQ: CVAC) COVID-19 vaccine and there are few catalysts from the rest of the company’s pipeline in 2022, according to BofA Securities.
JMP Securities Initiates Coverage On CureVac with Market Outperform Rating, Announces Price Target of $52
JMP Securities analyst Roy Buchanan initiates coverage on CureVac (NASDAQ:CVAC) with a Market Outperform rating and announces Price Target of $52.
52 Biggest Movers From Friday
Gainers
Splash Beverage Group, Inc. (NASDAQ: SBEV) shares gained 118.9% to settle at $4.18 on Friday. Splash Beverage recently announced it has received authorization to sell its TapouT performance drink in Walmart stores across Florida metropolitan areas.
CureVac Chief Technology Officer Announced Resignation to Pursue New Career outside Biotech Industry
CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced that the company's Chief Technology Officer, Dr. Mariola Fotin-Mleczek, will resign from CureVac effective January 31, 2022.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
CureVac Announces Co. Expects To Start A Phase 1 Clinical Trial Assessing CV2CoV In The First Quarter Of 2022; Expects To Start Assessing A Modified Second-generation COVID-19 mRNA Vaccine Candidate In A Phase 1 Trial In The Third Quarter Of 2022
CureVac N.V. (the “Company”) published today its timeline for the following programs:
·
Second-Generation Infectious Disease Program in Collaboration with GlaxoSmithKline